Vascular Disruptive Agents for the Treatment of Cancer (Paperback)
  • Vascular Disruptive Agents for the Treatment of Cancer (Paperback)
zoom

Vascular Disruptive Agents for the Treatment of Cancer (Paperback)

(editor)
£139.99
Paperback 256 Pages / Published: 20/11/2014
  • We can order this

Usually dispatched within 3 weeks

  • This item has been added to your basket
Angiogenesis (formation of new vessels from pre-existing ones) is a crucial early event in the process of tumor development. New vessels supply the tumor with nutrients that are needed for further local growth and enable distant metastases (Folkman 1995). Judah Folkman (1971) highlighted the potential therapeutic imp- cations of tumor angiogenesis. He hypothesized that if tumor angiogenesis is inhibited, then tumor growth and metastasis will be impaired greatly or even impossible. The subsequent quest for endogenous and exogenous inhibitors of angiogenesis has yielded a variety of promising therapeutic agents that block one or more angiogenic pathways, a few of which have been approved by the FDA (e. g. , bevacizumab, sorafenib, sunitinib) for use as single agents or in combination with chemotherapy in specific populations of cancer patients (Sessa et al. 2008). There has also been a dramatic expansion in the exploration of novel anti-angiogenic agents pre-clinically and in clinical trials (Ferrara 2002). Some of the most promising data comes from the development of agents that inhibit one of the key growth factors involved in tumor angiogenesis - vascular endothelial growth factor (VEGF) (Ferrara et al. 2003). Bevacizumab is a monoclonal antibody against VEGF that was the first an- angiogenic agent that improved significantly the overall survival of patients with colorectal and non-squamous non-small cell lung cancer (Ferrara et al. 2005). Various agents that target tumor angiogenesis are currently under investigation in different cancer types in many clinical trials (Ferrara and Kerbel 2005).

Publisher: Springer-Verlag New York Inc.
ISBN: 9781489982261
Number of pages: 256
Weight: 415 g
Dimensions: 235 x 155 x 14 mm
Edition: 2010 ed.

You may also be interested in...

Cancer
Added to basket
£12.50
Paperback
The Biology of Cancer
Added to basket
Cancer: A Very Short Introduction
Added to basket
The Cancer Survivor's Companion
Added to basket
The Emperor of All Maladies
Added to basket
Oxford Handbook of Clinical Haematology
Added to basket
£34.99
Part-work (fascículo)
Survival Lessons
Added to basket
The End of Your Life Book Club
Added to basket
Beat Cancer
Added to basket
£14.99
Paperback
Until Further Notice, I Am Alive
Added to basket
Medicine Hands
Added to basket
£29.99
Paperback
Beating Cancer with Nutrition
Added to basket
Added Time
Added to basket
£6.99
Paperback
Radical Remission
Added to basket
C List
Added to basket
£10.99
Paperback

Please sign in to write a review

Your review has been submitted successfully.